Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference

Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference




Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference

NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) will participate in the Credit Suisse 31st Annual Global Healthcare Conference on Thursday, November 10th, 2022 at the Terranea Resort in Rancho Palos Verdes, CA. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 12:50 p.m. (Eastern Time).

This audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48 hours after the live webcast.

Contacts

Press Contact:


Linda Fedow

(732) 524-6071

Investor Contact:


Raychel Kruper

(732) 524-6164